Myriad Genetics, Inc.

NasdaqGS:MYGN Rapporto sulle azioni

Cap. di mercato: US$2.5b

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Myriad Genetics Gestione

Gestione criteri di controllo 2/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Paul Diaz

Amministratore delegato

US$12.1m

Compenso totale

Percentuale dello stipendio del CEO9.0%
Mandato del CEO4yrs
Proprietà del CEO0.5%
Durata media del management2.6yrs
Durata media del Consiglio di amministrazione4.5yrs

Aggiornamenti recenti sulla gestione

Recent updates

Is Myriad Genetics (NASDAQ:MYGN) Weighed On By Its Debt Load?

Jul 17
Is Myriad Genetics (NASDAQ:MYGN) Weighed On By Its Debt Load?

Is Myriad Genetics, Inc. (NASDAQ:MYGN) Trading At A 33% Discount?

Jun 05
Is Myriad Genetics, Inc. (NASDAQ:MYGN) Trading At A 33% Discount?

Myriad Genetics, Inc.'s (NASDAQ:MYGN) Price Is Right But Growth Is Lacking After Shares Rocket 26%

May 11
Myriad Genetics, Inc.'s (NASDAQ:MYGN) Price Is Right But Growth Is Lacking After Shares Rocket 26%

Analysts Have Made A Financial Statement On Myriad Genetics, Inc.'s (NASDAQ:MYGN) First-Quarter Report

May 09
Analysts Have Made A Financial Statement On Myriad Genetics, Inc.'s (NASDAQ:MYGN) First-Quarter Report

Does Myriad Genetics (NASDAQ:MYGN) Have A Healthy Balance Sheet?

Mar 28
Does Myriad Genetics (NASDAQ:MYGN) Have A Healthy Balance Sheet?

An Intrinsic Calculation For Myriad Genetics, Inc. (NASDAQ:MYGN) Suggests It's 37% Undervalued

Feb 02
An Intrinsic Calculation For Myriad Genetics, Inc. (NASDAQ:MYGN) Suggests It's 37% Undervalued

Myriad Genetics' Strategic Growth Fuels Bullish Outlook

Jan 31

Revenues Working Against Myriad Genetics, Inc.'s (NASDAQ:MYGN) Share Price

Dec 18
Revenues Working Against Myriad Genetics, Inc.'s (NASDAQ:MYGN) Share Price

Is Myriad Genetics (NASDAQ:MYGN) Using Debt Sensibly?

Aug 07
Is Myriad Genetics (NASDAQ:MYGN) Using Debt Sensibly?

Calculating The Intrinsic Value Of Myriad Genetics, Inc. (NASDAQ:MYGN)

Apr 13
Calculating The Intrinsic Value Of Myriad Genetics, Inc. (NASDAQ:MYGN)

Myriad: Trying To Find Its Footing In An Evolving Industry

Sep 26

Myriad Genetics receives expanded coverage in Japan for breast cancer diagnostic system

Aug 25

Are Investors Undervaluing Myriad Genetics, Inc. (NASDAQ:MYGN) By 50%?

Aug 05
Are Investors Undervaluing Myriad Genetics, Inc. (NASDAQ:MYGN) By 50%?

Myriad Genetics Q2 2022 Earnings Preview

Aug 03

Myriad Genetics touts study results of GeneSight test on depression remission rates

Jul 12

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Paul Diaz rispetto agli utili di Myriad Genetics?
DataCompenso totaleStipendioGuadagni aziendali
Jun 30 2024n/an/a

-US$155m

Mar 31 2024n/an/a

-US$235m

Dec 31 2023US$12mUS$1m

-US$263m

Sep 30 2023n/an/a

-US$274m

Jun 30 2023n/an/a

-US$248m

Mar 31 2023n/an/a

-US$146m

Dec 31 2022US$11mUS$1m

-US$112m

Sep 30 2022n/an/a

-US$77m

Jun 30 2022n/an/a

-US$18m

Mar 31 2022n/an/a

-US$8m

Dec 31 2021US$13mUS$1m

-US$27m

Sep 30 2021n/an/a

-US$57m

Jun 30 2021n/an/a

-US$97m

Mar 31 2021n/an/a

-US$148m

Dec 31 2020US$16mUS$383k

-US$224m

Compensazione vs Mercato: La retribuzione totale di Paul ($USD 12.11M ) è superiore alla media delle aziende di dimensioni simili nel mercato US ($USD 6.76M ).

Compensazione vs guadagni: La retribuzione di Paul è aumentata nonostante l'azienda non sia redditizia.

AMMINISTRATORE DELEGATO

Paul Diaz (62 yo)

4yrs

Mandato

US$12,108,359

Compensazione

Mr. Paul J. Diaz serves as the Member of Advisory Board at Thornton Capital, LLC. He has been the Chief Executive Officer, President and Director of Myriad Genetics, Inc. since August 13, 2020. He serves a...

Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Paul Diaz
CEO, President & Director4yrsUS$12.11m0.47%
$ 11.9m
Samraat Raha
Chief Operating Officerless than a yearUS$5.02mNessun dato
Dale Muzzey
Chief Scientific Officer2.6yrsUS$2.23m0.12%
$ 3.0m
Mark Verratti
Chief Commercial Officer7yrsUS$2.88m0.33%
$ 8.3m
Scott Leffler
Chief Financial Officerless than a yearNessun datoNessun dato
Natalie Munk
Principal Accounting Officer2.2yrsNessun dato0.049%
$ 1.2m
Kevin Haas
Chief Technology Officer3.5yrsUS$1.64m0.15%
$ 3.7m
Matthew Scalo
Senior Vice President of Investor Relationsno dataNessun datoNessun dato
Justin Hunter
Interim General Counsel & Corporate Secretary3.5yrsNessun datoNessun dato
Glenn Farrell
Senior VP & Chief Marketing Officer1.7yrsNessun datoNessun dato
Shereen Solaiman
Chief People Officer1.4yrsNessun dato0.0031%
$ 78.8k
Patrick Burke
Executive Vice President of Strategy & Innovation3.3yrsNessun datoNessun dato

2.6yrs

Durata media

50yo

Età media

Gestione esperta: Il team dirigenziale di MYGN è considerato esperto (durata media dell'incarico 2.6 anni).

Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Paul Diaz
CEO, President & Director4yrsUS$12.11m0.47%
$ 11.9m
Paul Bisaro
Independent Director1.8yrsUS$258.48k0.027%
$ 675.8k
Lee Newcomer
Independent Director4.9yrsUS$447.99k0.073%
$ 1.8m
Daniel Skovronsky
Independent Director4.1yrsUS$433.49k0.077%
$ 1.9m
Colleen Reitan
Independent Director4.9yrsUS$443.49k0.080%
$ 2.0m
Heinrich Dreismann
Independent Director14.2yrsUS$443.49k0.13%
$ 3.2m
S. Phanstiel
Independent Chair of the Board14.9yrsUS$563.49k0.16%
$ 4.0m
Rashmi Kumar
Independent Director3.9yrsUS$433.49k0.076%
$ 1.9m

4.5yrs

Durata media

63.5yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di MYGN sono considerati esperti (durata media dell'incarico 4.5 anni).